BerandaZEAL • CPH
add
Zealand Pharma A/S
Tutup sebelumnya
kr 427,50
Rentang hari
kr 427,70 - kr 439,90
Rentang tahun
kr 306,10 - kr 788,00
Kapitalisasi pasar
30,57Â M DKK
Volume Rata-Rata
354,47Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (DKK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 49,57Â jt | 1.022,74% |
Biaya operasional | 510,89Â jt | 42,98% |
Penghasilan bersih | -404,23Â jt | -51,74% |
Margin laba bersih | -815,50 | 86,48% |
Penghasilan per saham | -5,75 | -52,52% |
EBITDA | -454,10Â jt | -33,52% |
Tarif pajak efektif | -10,23% | — |
Neraca
Total aset
Total liabilitas
| (DKK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 16,17Â M | 90,65% |
Total aset | 16,80Â M | 74,43% |
Total liabilitas | 1,63Â M | 118,92% |
Total ekuitas | 15,16 M | — |
Saham yang beredar | 70,29 jt | — |
Harga terhadap nilai buku | 1,98 | — |
Tingkat pengembalian aset | -6,79% | — |
Tingkat pengembalian modal | -7,30% | — |
Arus Kas
Perubahan kas bersih
| (DKK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -404,23Â jt | -51,74% |
Kas dari operasi | -443,77Â jt | -50,26% |
Kas dari investasi | -855,43Â jt | 85,92% |
Kas dari pembiayaan | -78,28Â jt | 71,25% |
Perubahan kas bersih | -1,27Â M | 80,87% |
Arus kas bebas | -257,65Â jt | -9,03% |
Tentang
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Didirikan
1 Apr 1997
Situs
Karyawan
440
